What Is a Mosaic Embryo
A mosaic embryo contains a mix of chromosomally normal and abnormal cells, a status detected during preimplantation genetic testing for aneuploidy (PGT-A). In IVF cycles, clinics biopsy a few trophectoderm cells from a blastocyst and report results as euploid, aneuploid, or mosaic, with mosaic cases showing varying proportions of abnormal cells according to published fertility research.
Clinics typically classify mosaic embryos as low-level or high-level based on the percentage of abnormal cells seen in the biopsy. Low-level mosaics often refer to roughly 20 to 40 percent abnormal cells, while high-level mosaics may indicate 40 to 80 percent, though exact cutoffs vary by laboratory and reporting system as outlined by the American Society for Reproductive Medicine.
How Clinics Handle Mosaic Embryo Transfers
Many IVF programs now offer elective transfer of certain mosaic embryos after genetic counseling, particularly when no euploid embryos are available. Published data from large cohort studies show that some mosaic transfers result in healthy live births, but they also carry a higher risk of miscarriage, preterm birth, or implantation failure compared with euploid transfers based on peer-reviewed fertility journals.
Clinics often prioritize low-level mosaics for transfer and may recommend prenatal diagnostic testing such as amniocentesis or chorionic villus sampling if a transfer proceeds. Regulatory bodies and professional societies, including the American Society for Reproductive Medicine, provide guidance that emphasizes informed consent, individualized risk assessment, and transparent reporting of outcomes per ASRM official positions.
Mosaic Embryo Success Rates and Data
Recent multi-center studies report that live birth rates from low-level mosaic transfers can approach those of some euploid transfers under specific conditions, while high-level mosaics show lower success and higher loss rates. Success depends on the type of mosaicism, the embryo's developmental stage, patient age, and the IVF clinic's laboratory practices as documented in fertility and sterility research.
Data from large IVF networks show that mosaic embryos are used in a growing share of transfers worldwide, especially in patients with limited euploid embryo availability. Clinics increasingly report cumulative live birth rates, miscarriage rates, and chromosomal abnormality rates for mosaic transfers to help patients weigh risks and benefits using ASRM and SART reporting frameworks.